奥沙利铂针联合替吉奥胶囊治疗对晚期胃癌患者CEA、CA199、TAM水平及生活质量的影响

江波; 林超

奥沙利铂针联合替吉奥胶囊治疗对晚期胃癌患者CEA、CA199、TAM水平及生活质量的影响

江波¹,
林超²

1. 四川大学华西广安医院肿瘤科
2. 广安区人民医院心电图室

基金项目:

基金：四川省卫生厅科研基金资助项目 (1201971);

计量
- 文章访问数: 2497
- HTML全文浏览量: 923
- PDF下载量: 41
- 被引次数: 0
出版历程
- 收稿日期: 2017-09-21

The Effect of Oxaliplatin Injection Combined with S-1 on Levels of CEA, CA199, TAM and the Quality of Life of Patients with Advanced Gastric Cancer

Jiang Bo ¹,
Lin Chao ²

Funds:

基金：四川省卫生厅科研基金资助项目 (1201971);

摘要

摘要: 目的探讨奥沙利铂针联合替吉奥胶囊治疗对晚期胃癌患者CEA、CA199、TAM水平及生活质量的影响.方法回顾性选取广安医院2013年1月至2016年6月期间收治的70例晚期胃癌患者的临床资料, 根据化疗方案不同分为研究组 (n=35, 奥沙利铂针联合替吉奥胶囊) 和对照组 (n=35, 替吉奥胶囊) .评估2组治疗的近期疗效, 于治疗前后检测血清标本中血清肿瘤标志物水平, 并进行毒性反应及生活质量评价.结果研究组总有效率、疾病控制率为45.71%、88.57%显著高于对照组的22.86%、71.43% (P<0.05) .2组治疗前血清肿瘤标志物癌胚抗原 (CEA) 、癌抗原199 (CA199) 、肿瘤相关物质 (TAM) 水平比较无统计学意义 (P>0.05) , 治疗后血清CEA、CA199、CEA水平均显著下降, 与治疗前相比差异有统计学意义 (P<0.05) , 且治疗后研究组血清CEA、CA199、CEA水平下降幅度显著大于对照组 (P<0.05) .研究组治疗期间及治疗后除恶心呕吐严重程度明显高于对照组外 (P<0.05) , 中性粒细胞减少、血小板减少、外周神经炎、肝或肾功能损害发生情况及严重程度与对照组相比无统计学意义 (P>0.05) .治疗后研究组KPS评分提高率显著高于对照组 (60.00%VS 31.42%) , 整体生活质量改善效果明显优于对照组 (P<0.05) .结论奥沙利铂针联合替吉奥胶囊治疗晚期胃癌能有效抑制肿瘤细胞生长转移, 缓解病情, 提高临床治疗疗效, 且安全性高, 对改善患者生活质量有重要意义.
- 奥沙利铂针 /
- 替吉奥胶囊 /
- 晚期 /
- 胃癌 /
- CEA /
- CA199 /
- TAM /
- 生活质量
Abstract: Objective To investigate the effect of oxaliplatin injection combined with S-1 on levels of carcinoembryonic antigen (CEA) , cancer antigen 199 (CA199) and tumor associated materials (TAM) and the quality of life of patients with advanced gastric cancer. Methods The clinical data of 70 patients with advanced gastric cancer treated in our hospital from January 2013 to June 2016 were retrospectively analyzed. According to different chemotherapy regimens, the patients were divided into the study group (n = 35, treated with oxaliplatin injection combined with S-1) and the control group (n = 35, treated with S-1) . The short-term curative effect in the two groups was evaluated, and levels of serum tumor markers were detected before and after the treatment.The toxicity and quality of life were evaluated. Results The total effective rate of treatment and disease control rate in the study group were significantly higher than those in the control group (45.71% and 88.57% vs 2.86% vs71.43%) (P < 0.05) . There were no significant differences in levels of serum CEA, CA199 and TAM between the two groups before the treatment (P > 0.05) . After the treatment, levels of serum CEA, CA199 and CEA were significantly decreased (P < 0.05) , and the decrease was significantly greater in the study group than in the control group (P < 0.05) . During and after the treatment, nausea and vomiting was more severe in the study group than in the control group (P < 0.05) , while the incidence rates of neutropenia, thrombocytopenia, peripheral neuritis and liver or kidney function damage showed no statistically significant difference (P > 0.05) . After the treatment, the improvement rate of KPS score in the study group was significantly higher than that in the control group (60% VS 31.42%) , and the overall improvement of the quality of life was significantly better than that in the control group (P < 0.05) . Conclusion Oxaliplatin injection combined with S-1 can effectively inhibit the growth and metastasis of tumor cells, remit the condition and improve the clinical efficacy with high safety in patients with advanced gastric cancer. It also can improve the quality of life of patients.
- Oxaliplatin injection /
- S-1 /
- Advanced /
- Gastric cancer /
- CEA /
- CA199 /
- TAM /
- Quality of life

HTML全文

参考文献(14)

[1]朱洁品, 娄金书.生长抑素联合多西他赛和替吉奥治疗进展期胃癌的临床研究[J].现代药物与临床, 2017, 32 (1) :124-128.
[2]智俊娜, 吴婷婷, 赵本慧, 等.替吉奥联合奥沙利铂与替吉奥联合多西他赛治疗晚期胃癌的临床观察[J].成都医学院学报, 2014, 9 (1) :34-37.
[3]芦兰, 许绿叶, 师幸伟.自体CIK细胞对晚期胃癌肿瘤标志物及生活质量的影响[J].广东医学, 2014, 35 (5) :698-700.
[4]中华人民共和国卫生部.中华人民共和国卫生行业标准:胃癌诊断标准 (WS 316-2010) [M].北京:中国标准出版社, 2010:353.
[5]陈智伟, 廖美琳.RECIST标准在肿瘤治疗疗效评价中的应用[J].中国肿瘤, 2004, 13 (10) :616-618.
[6]汪正广, 齐东江, 李嘉嘉, 等.中晚期胃癌患者术后化疗联合黄芪颗粒治疗对生活质量及免疫功能的影响[J].安徽医科大学学报, 2014, 49 (12) :1771-1774.
[7]韩茜, 李五生, 陈卫东, 等.替吉奥联合健脾丸对老年结直肠癌转移患者血清肿瘤标志物、COX-2及MMP-2水平影响研究[J].中华中医药学刊, 2016, 34 (11) :2734-2737.
[8]	[8]KIM J H, JUN KHJUNG H.Prognostic value of preoperative serum levels of five tumor markers (carcinoembryonic antigen, CA19-9, Alpha-fetoprotein, CA72-4, and CA125) in uastric cancer[J].Hepatogastroenterology, 2014, 61 (131) :863-869.
[9]	[9]LEE E C, YANG J Y, LEE K G, et al.The value of postoperative serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for the early detection of gastric cancer recurrence after curatme resection[J].Gastric Cancer, 2014, 14 (4) :221-228.
[10]	[10]HUANG Z B, ZHOU X, XU J, et al.Prognostic value of preopera tme serum tumor markers in gastric Cancer[J].World J Clin Oncol, 2014, 5 (2) :170-176.
[11]刘云军, 何志江, 黄毅超, 等.替吉奥联合奥沙利铂对晚期胃癌患者TAM、CEA、CA72-4的影响[J].实用癌症杂志, 2014, 29 (5) :506-508.
[12]吴福道, 张小静, 蔡辉, 等.替吉奥联合奥沙利铂治疗晚期胃癌的临床疗效观察[J].重庆医学, 2015, 44 (13) :1835-1837.
[13]涂德军, 洪俊强, 张启龙, 等.奥沙利铂联合S-1胶囊方案和FOLFOX6方案治疗晚期胃癌的疗效观察[J].西部医学, 2014, 26 (9) :1158-1160.
[14]张虎, 曹登科, 刘海威.奥沙利铂片联合替吉奥胶囊治疗中晚期胃癌的远期临床疗效研究[J].中国临床药理学杂志, 2016, 32 (21) :1971-1973.

相关文章(20)

[1]	陶映壁, 翟秋菊, 马思佳, 张明珠. 多元化健康教育对牙周加速成骨正畸手术患者生活质量及焦虑的影响, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20241027
[2]	马文妮, 冯雯娟, 马子林, 范咏诗, 马懿, 黄英. 自我管理在B型主动脉夹层患者出院准备度及生活质量间的中介效应, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20240530
[3]	裴瑶瑶, 许章英, 肖炜, 黎秀贤, 胡婷婷. 希望在恶性肿瘤复发患者自我感受负担和生活质量间的中介效应, 昆明医科大学学报.
[4]	张云惠, 孙杨, 贺谢巧, 陶德智, 罗发梦, 张海燕. 叙事护理对消化道恶性肿瘤患者心理痛苦及生活质量的影响, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20230810
[5]	吴江, 代水芬, 刘琴, 杨寿涛, 张江, 杨娇, 关琼瑶. 鼻咽癌同期放化疗患者实施营养临床护理路径对生活质量的影响, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20230510
[6]	李鸿. 老年晚期恶性梗阻性黄疸患者实时超声弹性成像定量分析对PTCD预后的评估价值, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20230206
[7]	李鸿. 老年晚期恶性梗阻性黄疸患者实时超声弹性成像定量分析对PTCD预后的预测价值, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20230123
[8]	金铭, 岑梅, 赵丽静. MDT驱动下的路径式SME对CHF患者生活质量的影响, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20221125
[9]	陈华英, 王维, 刘宝玲, 包艳, 胡蕾. 标准化管理模式对改善强直性脊柱炎患者生活质量的影响, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20210605
[10]	吴江, 费严焰, 代水芬, 杨莉, 周倩, 张玲, 石涛. 规范化营养干预对鼻咽癌放疗患者生活质量的影响, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20210728
[11]	丁哲宇, 寸英丽, 查勇, 代佑果, 张文, 张中红, 杜锋, 万崇华. 生命质量测定量表体系之胃癌量表 (QLICP-STV2.0) 的修订, 昆明医科大学学报.
[12]	郑锦红. 吞咽功能训练联合喂养指导对脑卒中吞咽障碍患者吞咽功能以及生活质量的影响, 昆明医科大学学报.
[13]	王园园. 人性照护理论对中晚期胃癌化疗患者的护理效果分析, 昆明医科大学学报.
[14]	池秀平. 全程优质护理对宫颈癌患者生活质量及焦虑抑郁情绪的影响, 昆明医科大学学报.
[15]	林忠菊. 集束化护理对腺样体肥大患儿生活质量及疼痛的护理效果分析, 昆明医科大学学报.
[16]	党艳艳. 奥瑞姆自理理论对老年糖尿病管理及生活质量的影响, 昆明医科大学学报.
[17]	杨倩蓉. 原位膀胱替代术患者术后生活质量的研究现状, 昆明医科大学学报.
[18]	杨艳. 心理护理干预对脑卒中患者生活质量的影响, 昆明医科大学学报.
[19]	吴安玥. 简体中文版MOS-HIV量表对HIV感染者/AIDS病人生活质量的评估, 昆明医科大学学报.
[20]	马永红. 超声联合肿瘤标志物在卵巢良恶性肿瘤中的鉴别诊断价值, 昆明医科大学学报.